ACROBiosystems is an internationally recognized manufacturer of recombinant proteins committed to supporting cancer immunotherapy. ACRO specializes in mammalian cell-based recombinant protein production and process development. ACRO’s goal is to support professionals from pharmaceutical companies, CRO, and research institutes in the field of immunotherapy by providing high-quality proteins, antibodies, and assay kits. ACRO have multiple offices and branches in North America, Europe, and Asia, spanning over 50 countries.



Core Technologies

●Proprietary HEK293 expression platform with strict animal-free and xeno-free conditions
●In-house developed enzymatic and chemical biotin labeling technique with bioactivity and labeling ratio optimized

Feature Brand

With years of experience, ACRO have established their own brands: MABSol® proteins and assay kits. The MABSol® brand products cover every step of the antibody drug development pipeline: diverse antigens for injection and selection; MABSol® Biotin Labeled Proteins for assay, immuno-capture and quantitative analysis; MABSol® Five-Minute MAB Isotyping Kits for antibody isotyping, purification media and MABSol® Fc Receptors for antibody optimization.

Product Feature Pages

Biotinylated Monkeypox virus Proteins
Emerging mutants from SARS-CoV-2 Variants
Targets of TME pathways

Targets for Antibody-Drug Conjugates

Bispecific antibody targets

Immune Checkpoint Proteins

MABSol® Biotin Labeled Proteins

Fc Receptor Proteins

CD3 Related Products

CD20 Related Products

CD47 Related Products

Product Catalog and Data

MABSOL® Biotinylated Proteins

Immune Checkpoint Proteins

Fc Receptor Family Proteins

SEC-HPLC Verified Proteins

Inhibitor Screening Kits

ROR Proteins


Biosimilar Drug targets

PD1 Pathway Proteins

Please contact us for any inquiries, questions, or information requests.
Tokyo Future Style, Inc.
TEL:029-851-9222 FAX:029-851-9220